Literature DB >> 32546051

Larger Middle Meningeal Arteries on Computed Tomography Angiography in Patients with Chronic Subdural Hematomas as Compared with Matched Controls.

Arnaud Pouvelle1, Geoffroy Pouliquen1, Kevin Premat1,2, Lydia Chougar1,2, Stéphanie Lenck1, Vincent Degos2,3, Nader-Antoine Sourour1, Bertrand Mathon2,4, Frédéric Clarençon1,2, Eimad Shotar1.   

Abstract

Chronic subdural hematomas (CSDHs) are one of the most prevalent head-trauma-related conditions. The middle meningeal artery (MMA) may participate in the pathophysiology of CSDHs. The aim of this study was to determine whether CSDHs are associated with large MMAs. Patients referred for CSDH embolization and having undergone a computed tomography angiography (CTA) before embolization were retrospectively included. For each CSDH patient, two age- and sex-matched controls with a CTA performed during the study period were selected. Size comparisons of the MMA were performed between MMAs ipsilateral to CSDHs, on the contralateral side, and in controls. Comparison was also made with angiographic measurements from CSDH embolization procedures. Seventy-five patients with CSDH with available CTAs prior to embolization were enrolled and 146 MMAs were measured. One hundred fifty controls were included and 288 MMAs were measured. The median diameter of the 94 MMAs ipsilateral to a CSDH (1.5 mm; interquartile range [IQR] 1.3-1.7) was significantly larger than that of control MMAs (1.28 mm; IQR 1.15-1.4) (p < 0.001). The median diameter of 52 MMAs on the side of a unilateral CSDH (1.6 mm; IQR 1.4-1.8) was larger than that of the 52 contralateral MMAs (1.4 mm; IQR 1.25-1.6) (p < 0.001). Among the characteristics of patients with CSDH, multiple surgeries were associated with significantly larger MMAs (>1.7 mm; p = 0.01). MMAs ipsilateral to CSDHs appear to be significantly larger as compared with contralateral MMAs and MMAs in a control population, suggesting the involvement of the MMA in the pathophysiology of CSDH.

Entities:  

Keywords:  chronic subdural hematoma; middle meningeal artery

Year:  2020        PMID: 32546051     DOI: 10.1089/neu.2020.7168

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  5 in total

1.  Long-Term Middle Meningeal Artery Caliber Reduction Following Trisacryl Gelatine Microsphere Embolization for the Treatment of Chronic Subdural Hematoma.

Authors:  Eimad Shotar; Eric Barberis; Lydia Chougar; Sacha Bensoussan; Damien Parat; Haroun Ghannouchi; Kevin Premat; Stephanie Lenck; Vincent Degos; Stéphane Lehericy; Nader-Antoine Sourour; Bertrand Mathon; Frédéric Clarençon
Journal:  Clin Neuroradiol       Date:  2022-07-07       Impact factor: 3.649

Review 2.  Middle meningeal artery embolization for treatment of chronic subdural hematoma.

Authors:  Ruben Mühl-Benninghaus
Journal:  Radiologie (Heidelb)       Date:  2022-10-04

3.  CTA-Based Patient-Tailored Femoral or Radial Frontline Access Reduces the Rate of Catheterization Failure in Chronic Subdural Hematoma Embolization.

Authors:  E Shotar; G Pouliquen; K Premat; A Pouvelle; S Mouyal; L Meyblum; S Lenck; V Degos; S Abi Jaoude; N Sourour; B Mathon; F Clarençon
Journal:  AJNR Am J Neuroradiol       Date:  2021-02-04       Impact factor: 3.825

4.  Middle meningeal artery embolization with subdural evacuating port system for primary management of chronic subdural hematomas.

Authors:  Austin Carpenter; Mitchell Rock; Ehsan Dowlati; Charles Miller; Jeffrey C Mai; Ai-Hsi Liu; Rocco A Armonda; Daniel R Felbaum
Journal:  Neurosurg Rev       Date:  2021-04-24       Impact factor: 2.800

5.  Factors correlated with the postoperative recurrence of chronic subdural hematoma: An umbrella study of systematic reviews and meta-analyses.

Authors:  Fulei Zhu; Haifeng Wang; Wenchen Li; Shuai Han; Jiangyuan Yuan; Chunyun Zhang; Zean Li; Guangyan Fan; Xuanhui Liu; Meng Nie; Li Bie
Journal:  EClinicalMedicine       Date:  2021-12-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.